Gene · 833
Papers4,113
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 4,113
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| T Cell engineering for cancer immunotherapy by manipulating mechanosensitive force-bearing receptors. | Front Bioeng Biotechnol | 2023 | 37560540 | PubTator, text mining | PubMed |
| Strategies for overcoming bottlenecks in allogeneic CAR-T cell therapy. | Front Immunol | 2023 | 37554322 | PubTator, text mining | PubMed |
| Antigen-dependent IL-12 signaling in CAR T cells promotes regional to systemic disease targeting. | Nat Commun | 2023 | 37550294 | PubTator, text mining | PubMed |
| Role of ferroptosis in esophageal cancer and corresponding immunotherapy. | World J Gastrointest Oncol | 2023 | 37546564 | PubTator, text mining | PubMed |
| Larynx myofibroblastic tumor, a rare case report. | Clin Case Rep | 2023 | 37546157 | PubTator, text mining | PubMed |
| Editorial: Expert opinions and perspectives in adoptive cell therapy for cancer: 2022. | Front Immunol | 2023 | 37545532 | PubTator, text mining | PubMed |
| Constitutive Turbodomains enhance expansion and antitumor activity of allogeneic BCMA CAR T cells in preclinical models. | Sci Adv | 2023 | 37540748 | PubTator, text mining | PubMed |
| Understanding NK cell biology for harnessing NK cell therapies: targeting cancer and beyond. | Front Immunol | 2023 | 37539051 | PubTator, text mining | PubMed |
| Base-editing screens illuminate variant effects in human hematopoiesis. | Cell Rep Methods | 2023 | 37533644 | PubTator, text mining | PubMed |
| Novel CD123×CD33 bicistronic chimeric antigen receptor (CAR)-T therapy has potential to reduce escape from single-target CAR-T with no more hematotoxicity. | Cancer Commun (Lond) | 2023 | 37525513 | PubTator, text mining | PubMed |
| Valproic acid increases CAR T cell cytotoxicity against acute myeloid leukemia. | J Immunother Cancer | 2023 | 37524506 | PubTator, text mining | PubMed |
| Chimeric antigen receptors in the brain: Can we tackle glioblastoma with engineered NK cells? | Neuro Oncol | 2023 | 37522296 | PubTator, text mining | PubMed |
| Targeting Potential of Innate Lymphoid Cells in Melanoma and Other Cancers. | Pharmaceutics | 2023 | 37514187 | PubTator, text mining | PubMed |
| CAR-T State of the Art and Future Challenges, A Regulatory Perspective. | Int J Mol Sci | 2023 | 37511562 | PubTator, text mining | PubMed |
| Deciphering the Signaling Mechanisms of Osteosarcoma Tumorigenesis. | Int J Mol Sci | 2023 | 37511127 | PubTator, text mining | PubMed |
| Innate Immunity in Cancer Biology and Therapy. | Int J Mol Sci | 2023 | 37510993 | PubTator, text mining | PubMed |
| Harnessing the Immune System: Current and Emerging Immunotherapy Strategies for Pediatric Acute Lymphoblastic Leukemia. | Biomedicines | 2023 | 37509525 | PubTator, text mining | PubMed |
| The Use of Targeted Cytokines as Cancer Therapeutics in Glioblastoma. | Cancers (Basel) | 2023 | 37509400 | PubTator, text mining | PubMed |
| Cellular Therapy for Lung Cancer: Focusing on Chimeric Antigen Receptor T (CAR T) Cells and Tumor-Infiltrating Lymphocyte (TIL) Therapy. | Cancers (Basel) | 2023 | 37509394 | PubTator, text mining | PubMed |
| Clinical Trials of Cellular Therapies in Solid Tumors. | Cancers (Basel) | 2023 | 37509328 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/833/papers?page=24